LEADER 01404nas--2200397---450-
001 990002988270203316
005 20110125133001.0
011   $a1871-5273
035   $a000298827
035   $aUSA01000298827
035   $a(ALEPH)000298827USA01
035   $a000298827
100   $a20071012a20069999km-y0itaa50------ba
101 0 $aeng
102   $aUS
110   $aaaazz--||||
200  1$aCNS & Neurological Disorders - Drug Targets
207  1$aVol.5, n.1 (2006)-
210   $aSan Francisco, CA$cBentham Science$d2006-
215   $av.$cill.$d28 cm
326   $aBimestrale
430  1$1001000157010$12001$aCurrent Drug Targets - CNS & Neurological Disorders
606 0 $aSistema nervoso centrale$xMalattie degenerative$xPeriodici
676   $a616.8
801  0$aIT$bsalbc$gISBD
856 4 $uhttp://www.ingentaconnect.com/content/ben/cnsnddt;jsessionid=1plhb26o2eh2e.henrietta$4.$zOnline da workstation autorizzate
856 4 $uhttp://www.ingentaconnect.com/content/ben/cnsnddt$4.$zOnline dal 2007
912   $a990002988270203316
958   $aFARM$bFondo$c5(2006)-9(2010);
959   $aSE
979   $aVITTORIANA$b90$c20071012$lUSA01$h1318
979   $aVITTORIANA$b90$c20071012$lUSA01$h1339
979   $aCARLA$b90$c20080318$lUSA01$h1053
979   $aPATRY$b90$c20110125$lUSA01$h1330
996   $aCNS & Neurological Disorders - Drug Targets$91028004
997   $aUNISA